Nickil Nayee, DPM
Podiatrist · Plano, TXNPI 1598230690
Payments from drug & device makers
What this record shows
32 manufacturers reported payments, led by Kerecis Limited at 36.8% of the total. Reporting peaked in 2023 at $7,506 and has fallen 88.7% since, to $851 in 2025.
Across 194 payments — averaging $68.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kerecis Limited$5K
- Smith+Nephew$2K
- Vilex LLC$1K
- Amgen$887
- Stryker$656
- Medline Industries LP$555
- plus $3K from 26 others
What the payments were for
- Travel & lodging$6,83252%
- Food & beverage$6,39448%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kerecis Limited | 13 | $4,870 |
| Smith+Nephew | 24 | $1,776 |
| Vilex LLC | 9 | $1,428 |
| Amgen(2 entities) | 26 | $887 |
| Stryker | 7 | $656 |
| Medline Industries LP | 4 | $555 |
| Paratek Pharmaceuticals, Inc. | 27 | $514 |
| Averitas Pharma Inc. | 15 | $447 |
| Arthrex | 1 | $392 |
| AbbVie | 18 | $348 |
| Melinta Therapeutics, LLC | 9 | $268 |
| Johnson & Johnson | 3 | $223 |
| Zimmer Biomet | 3 | $102 |
| Nevro Corp. | 6 | $99 |
| Urgo Medical North America, LLC | 1 | $99 |
| Innovation Technologies Inc | 3 | $82 |
| Organogenesis Inc. | 4 | $79 |
| Convatec Inc. | 2 | $52 |
| GRT US Holding, Inc. | 2 | $51 |
| Pylant Medical | 1 | $46 |
| Mimedx Group, Inc. | 2 | $42 |
| IBSA Pharma Inc. | 2 | $32 |
| Medtronic | 2 | $27 |
| Nuo Therapeutics | 2 | $26 |
| Globus Medical | 1 | $21 |
| Inari Medical, Inc. | 1 | $20 |
| KCI USA, Inc. | 1 | $17 |
| Hartmann USA, Inc. | 1 | $15 |
| Hydrofera LLC | 1 | $15 |
| Nalu Medical, Inc. | 1 | $14 |
| Next Science LLC | 1 | $13 |
| Molnlycke Health Care US, LLC | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 SurgiClose$13,189
- Kerecis Omega3 Marigen$5,434
- Kerecis Omega3 GraftGuide$4,656
- HINTERMANN$1,213
- Grafix$741
- Stravix$691
- KRYSTEXXA$640
- Oasis$623
- PICO$623
- RENASYS TOUCH$623
- Versajet$623
- STAR$331
- GRAFIX PL$267
- DALVANCE$125
- NUZYRA$124
- VA-LCP$117
- Kimyrsa$105
How this compares
$13,226 in reported general payments places this provider in the 85th percentile of 470 podiatrist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Linezolid | 12 | $559 |
| Doxycycline Hyclate | 38 | $326 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 11 | $238 |
| Methylprednisolone | 27 | $171 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Plano
- Aamir AhmedPlano$24K
- Sirisha PokalaPlano$13K
- Brian CarpenterFort Worth$1.2M
- Gary LepowHouston$1M
- Wayne HurstCedar Park$625K
- Calvin RushingSunnyvale$452K
- Alan GarrettFort Worth$185K
- Gregory JarygaFt Worth$175K
- Brandon LampeMesquite$154K
- Andrew SchneiderHouston$150K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.